4591 — Ribomic Share News
0.000.00%
Table: Ribomic - 9-MTH parent results
Table: Ribomic -2018/19 parent forecast
Table: Ribomic - 6-MTH parent results
Table: Ribomic - Q1 parent results
Brief: Ribomic announces exercise of options
Table: Ribomic -2017/18 parent results
Brief: Ribomic announces exercise of options
Table: Ribomic - 9-MTH parent results
Brief: Ribomic announces exercise of options in January
Brief: Ribomic announces exercise of options
Brief: Ribomic says exercise of options
Table: Ribomic - 6-MTH parent results
Brief: Ribomic signs collaborative research contract with SEIKAGAKU
Brief: Ribomic to set up wholly owned subsidiary RIBOMIC USA
Table: Ribomic - Q1 parent results
Table: Ribomic -2016/17 parent results
Brief: Ribomic signs license agreement with Otsuka Pharmaceutical
Brief: RIBOMIC plans joint research agreement with Astellas pharma
Brief: Ribomic gets patent for RBM004 in U.S